Blood Viscometer Market Share

  • Report ID: 5474
  • Published Date: Jan 03, 2024
  • Report Format: PDF, PPT

Blood Viscometer Market Share

North American Market Forecast

The blood viscometer market in the North America region is expected to hold the largest revenue share of about 30% during the forecast period. Because of the expanding number of illness diagnostic procedures including viscosity and rheology analysis, technical improvements, increased packaged food consumption, and the presence of large companies, North America is predicted to have a considerable market share in the viscometer industry. The food packaging business in North America was valued at about 92 billion dollars in 2020. By 2028, the market is expected to be worth roughly 135.5 billion US dollars. The examined market is expanding as a result of the new product introductions in the area. For instance, RheoSense, Inc. introduced VROC Initium One Plus, the autonomous viscometer with the greatest level of accuracy, in August 2020.

European Market Statistics

Blood viscometer market in Europe is anticipated to hold second second-largest revenue share of about 25% during the forecast period. Europe prioritizes research and development to a similar extent-technological progress, such as the creation of lightweight, user-friendly gadgets. In the context of medicine and research, these new viscometers are highly valued since they provide measurements that are more precise and effective. All things considered, the market is moving toward more sophisticated and practical solutions.

Research Nester
Blood Viscometer Market Size

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5474
  • Published Date: Jan 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Ans: Increasing cardiovascular disease and advancement in technology are the major factors driving the growth of the blood viscometer market.

The market size of blood viscometer is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are BioFluid Technology Inc., Thermo Fisher Scientific, RheoSense, Anton Paar GmbH, China BeiJing Steellex Scientific Instrument Co., Scientific Instrument Co. Ltd., Health Onvector, and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying